{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:20:59Z","timestamp":1787728859077,"version":"build-2784847793"},"reference-count":44,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1248\/bpb.b19-01073","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T18:08:23Z","timestamp":1588270103000},"page":"864-872","source":"Crossref","is-referenced-by-count":31,"title":["<i>Dendrobium officinale<\/i> Attenuates Myocardial Fibrosis <i>via<\/i> Inhibiting EMT Signaling Pathway in HFD\/STZ-Induced Diabetic Mice"],"prefix":"10.1248","volume":"43","author":[{"given":"Jie","family":"Zeng","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Sciences, Southwest University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongning","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Southwest University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhubo","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Southwest University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Southwest University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract.<\/i>, 138<\/b>, 271\u2013281 (2018)."},{"key":"2","unstructured":"2) DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia<\/i>, 53<\/b>, 1270\u20131287 (2010)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chen PH, Lin YK, Chang CK, Chiang SJ, Tsai SY. Dysregulation of glucose metabolism since young adulthood increases the risk of cardiovascular diseases in patients with bipolar disorder. Kaohsiung J. Med. Sci.<\/i>, 33<\/b>, 630\u2013636 (2017).","DOI":"10.1016\/j.kjms.2017.07.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yan B, Singla DK. Transplanted induced pluripotent stem cells mitigate oxidative stress and improve cardiac function through the Akt cell survival pathway in diabetic cardiomyopathy. Mol. Pharm.<\/i>, 10<\/b>, 3425\u20133432 (2013).","DOI":"10.1021\/mp400258d"},{"key":"5","unstructured":"5) Diao X, Shen E, Wang X, Hu B. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice. Mol. Med. Rep.<\/i>, 4<\/b>, 633\u2013640 (2011)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ. Res.<\/i>, 107<\/b>, 1058\u20131070 (2010).","DOI":"10.1161\/CIRCRESAHA.110.223545"},{"key":"7","unstructured":"7) Regan TJ, Ahmed S, Haider B, Moschos C, Weisse A. Diabetic cardiomyopathy: experimental and clinical observations. N. J. Med.<\/i>, 91<\/b>, 776\u2013778 (1994)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Liu M, Liu L, Bai M, Zhang L, Ma F, Yang X, Sun S. Hypoxia-induced activation of Twist\/miR-214\/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis. Biochem. Biophys. Res. Commun.<\/i>, 495<\/b>, 2324\u20132330 (2018).","DOI":"10.1016\/j.bbrc.2017.12.130"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia<\/i>, 57<\/b>, 660\u2013671 (2014).","DOI":"10.1007\/s00125-014-3171-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zou C, Liu X, Xie R, Bao Y, Jin Q, Jia X, Li L, Liu R. Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. Biochem. Biophys. Res. Commun.<\/i>, 486<\/b>, 930\u2013936 (2017).","DOI":"10.1016\/j.bbrc.2017.03.127"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yan XL, Wang YY, Yu ZF, Tian MM, Li H. Peroxisome proliferator-activated receptor-gamma activation attenuates diabetic cardiomyopathy via<\/i> regulation of the TGF-\u03b2\/ERK pathway and epithelial-to-mesenchymal transition. Life Sci.<\/i>, 213<\/b>, 269\u2013278 (2018).","DOI":"10.1016\/j.lfs.2018.09.004"},{"key":"12","unstructured":"12) Sun B, Zhang D, Zhao N, Zhao X. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Oncotarget<\/i>, 8<\/b>, 30502\u201330510 (2017)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mai J, Chen Y, Qiu Q, Yuan W, Wang J. GW25-e5210 Endothelial-mesenchymal transition contributes to cardiac fibrosis induced by dyssynchronous heart failure through heterogeneity of mechanical stretch in a canine model. J. Am. Coll. Cardiol.<\/i>, 64<\/b>, C62\u2013C63 (2014).","DOI":"10.1016\/j.jacc.2014.06.298"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, Mcmullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med.<\/i>, 13<\/b>, 952\u2013961 (2007).","DOI":"10.1038\/nm1613"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Frauke B, Christian R, Richard B, Achim W, Florian R, Julia B, Ulrike S, Stefan F, Alois F, Ferdinand HD. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn\u2019s disease. Inflamm. Bowel Dis.<\/i>, 14<\/b>, 1514\u20131527 (2008).","DOI":"10.1002\/ibd.20590"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhao M, Han J. Dendrobium officinale<\/i> Kimura et Migo ameliorates insulin resistance in rats with diabetic nephropathy. Med. Sci. Monit. Basic Res.<\/i>, 24<\/b>, 84\u201392 (2018).","DOI":"10.12659\/MSMBR.909242"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Xu XB, Ma XY, Lei HH, Song HM, Ying QC, Xu MJ, Liu SB, Wang HZ. Proteomic analysis reveals the mechanisms of Mycena dendrobii<\/i> promoting transplantation survival and growth of tissue culture seedlings of Dendrobium officinale.<\/i> J. Appl. Microbiol.<\/i>, 118<\/b>, 1444\u20131455 (2015).","DOI":"10.1111\/jam.12781"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Xiang L, Sze CWS, Ng TB, Tong Y, Shaw PC, Tang CWS, Zhang YBK. Polysaccharides of Dendrobium officinale<\/i> inhibit TNF-alpha-induced; apoptosis in A-253 cell line. Inflamm. Res.<\/i>, 62<\/b>, 313\u2013324 (2013).","DOI":"10.1007\/s00011-012-0584-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Xiang L, Shaw PC, Sze CW, Yao T, Zhang Y. Dendrobium officinale<\/i> polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sj\u00f6gren\u2019s syndrome mice. Int. Immunopharmacol.<\/i>, 11<\/b>, 2025\u20132032 (2011).","DOI":"10.1016\/j.intimp.2011.08.014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Zhao X, Dou M, Zhang Z, Zhang D, Huang C. Protective effect of Dendrobium officinale polysaccharides on H2<\/sub>O2<\/sub>-induced injury in H9c2 cardiomyocytes. Biomed. Pharmacother.<\/i>, 94<\/b>, 72\u201378 (2017).","DOI":"10.1016\/j.biopha.2017.07.096"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhang Z, Zhang D, Dou M, Li Z, Zhang J, Zhao X. Dendrobium officinale<\/i> Kimura et Migo attenuates diabetic cardiomyopathy through inhibiting oxidative stress, inflammation and fibrosis in streptozotocin-induced mice. Biomed. Pharmacother.<\/i>, 84<\/b>, 1350\u20131358 (2016).","DOI":"10.1016\/j.biopha.2016.10.074"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Skovs\u00f8 S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J. Diabetes Invest.<\/i>, 5<\/b>, 349\u2013358 (2014).","DOI":"10.1111\/jdi.12235"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet. Med.<\/i>, 19<\/b>, 527\u2013534 (2002).","DOI":"10.1046\/j.1464-5491.2002.00745.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Li S, Huang Q, Zhang L, Qiao X, Zhang Y, Tang F, Li Z. Effect of CAPE-pNO2 against type 2 diabetes mellitus via<\/i> the AMPK\/GLUT4\/ GSK3\u03b2\/PPAR\u03b1 pathway in HFD\/STZ-induced diabetic mice. Eur. J. Pharmacol.<\/i>, 853<\/b>, 1\u201310 (2019).","DOI":"10.1016\/j.ejphar.2019.03.027"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tesch GH, Allen TJ. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology<\/i>, 12<\/b>, 261\u2013266 (2007).","DOI":"10.1111\/j.1440-1797.2007.00796.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Decl\u00e8ves AE, Sharma K. New pharmacological treatments for improving renal outcomes in diabetes. Nat. Rev. Nephrol.<\/i>, 6<\/b>, 371\u2013380 (2010).","DOI":"10.1038\/nrneph.2010.57"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia<\/i>, 44<\/b>, 929\u2013945 (2001).","DOI":"10.1007\/s001250100580"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care<\/i>, 24<\/b>, 362\u2013365 (2001).","DOI":"10.2337\/diacare.24.2.362"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ye G, Gao H, Lin Y, Ding D, Liao X, Zhang H, Chi Y, Dong S. Peroxisome proliferator-activated receptor A\/G reprogrammes metabolism associated with lipid accumulation in macrophages. Metabolomics<\/i>, 15<\/b>, 36 (2019).","DOI":"10.1007\/s11306-019-1485-6"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Bragt MC, Popeijus HE. Peroxisome proliferator-activated receptors and the metabolic syndrome. Physiol. Behav.<\/i>, 94<\/b>, 187\u2013197 (2008).","DOI":"10.1016\/j.physbeh.2007.11.053"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPAR\u03b1-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology<\/i>, 38<\/b>, 123\u2013132 (2003).","DOI":"10.1053\/jhep.2003.50307"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA, Davis RJ.JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science<\/i>, 339<\/b>, 218\u2013222 (2013).","DOI":"10.1126\/science.1227568"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Vernia S, Cavanagh-Kyros J, Garcia-Haro L, Sabio G, Barrett T. The PPAR\u03b1-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway. Cell Metab.<\/i>, 20<\/b>, 512\u2013525 (2014).","DOI":"10.1016\/j.cmet.2014.06.010"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Win S, Than T, Fernandez-Checa J, Kaplowitz N. JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death. Cell Death Dis.<\/i>, 5<\/b>, e989 (2014).","DOI":"10.1038\/cddis.2013.522"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Altamimi TR, Gao S, Karwi QG, Fukushima A, Rawat S, Wagg CS, Zhang LY, Lopaschuk GD. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency. Metabolism<\/i>, 98<\/b>, 37\u201348 (2019).","DOI":"10.1016\/j.metabol.2019.06.005"},{"key":"36","unstructured":"36) Toedebusch R, Belenchia A, Pulakat L. Diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures. Front. Physiol.<\/i>, 9<\/b>, 453 (2018)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Balah A, Ezzat O, Akool ES. Vitamin E inhibits cyclosporin A-induced CTGF and TIMP-1 expression by repressing ROS-mediated activation of TGF-\u03b2\/Smad signaling pathway in rat liver. Int. Immunopharmacol.<\/i>, 65<\/b>, 493\u2013502 (2018).","DOI":"10.1016\/j.intimp.2018.09.033"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev.<\/i>, 11<\/b>, 15\u201322 (2000).","DOI":"10.1016\/S1359-6101(99)00025-8"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Yang L, Hu J, Hao HZ, Yin Z, Liu G, Zou XJ. Sodium tanshinone IIA sulfonate attenuates the transforming growth factor-\u03b21-induced differentiation of atrial fibroblasts into myofibroblasts in vitro.<\/i> Int. J. Mol. Med.<\/i>, 35<\/b>, 4 (2015).","DOI":"10.3892\/ijmm.2015.2087"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Wu J, Chen X, Liu X, Huang S, He C, Chen B, Liu Y. Autophagy regulates TGF-\u03b22-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. Mol. Med. Rep.<\/i>, 17<\/b>, 3607\u20133614 (2018).","DOI":"10.3892\/mmr.2017.8360"},{"key":"41","unstructured":"41) Willis B, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell Mol. Physiol.<\/i>, 293<\/b>, L525\u2013L534 (2007)."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Han Q, Lin L, Zhao B, Wang N, Liu X. Inhibition of mTOR ameliorated bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition. Biochem. Biophys. Res. Commun.<\/i>, 500<\/b>, 839\u2013845 (2018).","DOI":"10.1016\/j.bbrc.2018.04.148"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Iderzorig T, Kellen J, Osude C, Singh S, Woodman JA, Garcia C, Puri N. Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC. Biochem. Biophys. Res. Commun.<\/i>, 496<\/b>, 770\u2013777 (2018).","DOI":"10.1016\/j.bbrc.2018.01.069"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Wang Z, Divanyan A, Jourd\u2019Heuil F, Goldman RD, Ridge KM, Jourd\u2019Heuil D, Lopez-Soler RI. Vimentin expression is required for the development of EMT-related renal fibrosis following unilateral ureteral obstruction in mice. Am. J. Physiol. Renal Physiol.<\/i>, 315<\/b>, F769\u2013F780 (2018).","DOI":"10.1152\/ajprenal.00340.2017"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01073\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T02:34:15Z","timestamp":1588818855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01073\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-01073","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}